SCHEMBL6076089

SCHEMBL6076089

N=C(NOC[C@@H](O)CN1CCCCC1)c1ccc[n+]([O-])c1.O=C(O[C@H](C(=O)O)[C@H](OC(=O)c1ccccc1)C(=O)O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 14/20 0.44
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 2/20 0.39
CYP2D6 P10635 1/20 0.39
HIF1A Q16665 1/20 0.39
TP53 P04637 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5699238 0.88 ABCB1 (0.44) ABCB1MAPK1SMN1; SMN2TSHRCYP2D6
SCHEMBL5699325 0.88 ABCB1 (0.44) ABCB1MAPK1SMN1; SMN2TSHRCYP2D6
SCHEMBL5699270 0.88 ABCB1 (0.44) ABCB1MAPK1SMN1; SMN2TSHRCYP2D6
Hydrochloric Acid SCHEMBL5699250 0.87 CYP2D6 (0.43) ABCB1MAPK1ALDH1A1SMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL3559483 0.87 CYP2D6 (0.43) ABCB1MAPK1ALDH1A1SMN1; SMN2TSHR
Maleic Acid SCHEMBL5699236 0.87 ABCB1 (0.45) ABCB1MAPK1ALDH1A1LMNAMAPT
Arimoclomol SCHEMBL5699321 0.81 HSF1 (0.47) ABCB1MAPK1MEN1KMT2A
SCHEMBL3572645 0.81 ABCB1 (0.47) ABCB1MAPK1TSHRCYP2D6HIF1A
Hydrochloric Acid SCHEMBL28996182 0.80 ABCB1 (0.47) ABCB1MAPK1ALDH1A1MEN1KMT2A
SCHEMBL5698929 0.78 ABCB1 (0.57) ABCB1MAPK1SMN1; SMN2TSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7126002-B2 Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds CYTRX CORPORATION (US) 2006-10-24 US disclosed